Photo

Photo detail

Rick Hancock

Stories this photo appears in:

Avid Bioservices Soars After Tumultuous Period

HEALTHCARE: Shares rise 40% after Q4 report

It turns out the reports of Avid Bioservices Inc.’s demise were an exaggeration.

Tease photo

Avid Aims for Rebound After CEO Departure

New Analyst Sets $5 Price Target

Tustin-based Avid Bioservices Inc. (Nasdaq: CDMO), a pharmaceutical contract manufacturer that’s seen its share of change the past year, might be returning to the light as its stock gains traction, and the attention of a new analyst.

Tease photo

Avid Names Interim CEO

Avid Bioservices Inc. (Nasdaq: CDMO) named board member and pharma industry vet Richard ‘Rick’ Hancock interim chief executive, succeeding Roger Lias, who has resigned from the company and its board of directors.

Tease photo